APP下载

糖网明目颗粒提取物对缺氧/高糖状态下血管内皮细胞肿瘤坏死因子—α、白细胞介素—1α表达的影响

2015-05-30蒿长英等

中国中医药信息杂志 2015年8期

蒿长英等

摘要:目的 观察糖网明目颗粒提取物对缺氧/高糖状态下血管内皮细胞EA.hy926炎症相关因子的影响,并探讨其作用机制。方法 以CoCl2和高浓度葡萄糖干预人脐静脉内皮细胞EA.hy926复制缺氧和高糖模型,MTT法检测细胞增殖能力,半定量RT-PCR检测炎症相关基因表达,ELISA检测炎症相关蛋白表达。结果 缺氧和高糖均能促进EA.hy926细胞增殖,显著上调肿瘤坏死因子-α(TNF-α)、白细胞介素-1α(IL-1α)基因和蛋白表达(P<0.05)。药物干预后,细胞增殖能力降低,TNF-α、IL-1α基因和蛋白表达水平显著降低(P<0.05)。结论 糖网明目颗粒提取物可能通过调控缺氧/高糖状态下内皮细胞TNF-α、IL-1α等炎症相关因子的mRNA和蛋白表达从而达到防治糖尿病视网膜病变的目的。

关键词:糖网明目颗粒提取物;糖尿病视网膜病变;肿瘤坏死因子-α;白细胞介素-1α;人脐静脉内皮细胞

DOI:10.3969/j.issn.1005-5304.2015.08.014

中图分类号:R285.5 文献标识码:A 文章编号:1005-5304(2015)08-0050-05

Effects of Tangwang Mingmu Granules on Expressions of TNF-α and IL-1α in Vascular Endothelial Cellsunder Hypoxia/High Glucose HAO Chang-ying1, CHEN Ming-xia2, GUO Ping3, MA Wen-bin1, LV Hai-bo3, DU Pei-pei1, ZHEN Lin-na3, LIU Ye4, LIAN Zeng-lin4 (1.Handian Group, Beijing Red Sun Pharmaceutical Co., Ltd., Beijing 100103, China;2.Beijing University of Chinese Medicine, Beijing 100029, China;3. Handian Group,Beijing Handian Pharmaceutical Co., Ltd., Beijing 100103, China;4.Beijing Handian Academy of Chinese Medicine, Beijing 100103, China)

Abstract:Objective To observe the effects of Tangwang Mingmu Granules on inflammation- associated cytokines in vascular endothelial cells EA.hy926 under hypoxic/high glucose. Methods CoCl2 and high glucose were used to make the hypoxic and high glucose model in human umbilical vein endothelial cell line EA.hy926. EA.hy926 cell proliferation was measured by MTT method. Gene and protein expression levels of inflammatory factors were detected by semi-quantitative RT-PCR and ELISA assay. Results Both hypoxia and high glucose promoted EA.hy926 cell proliferation. The gene and protein expressions of TNF-α and IL-1α were significantly up-regulated under the same condition (P<0.05). The cell proliferation, TNF-α, IL-1α mRNA and protein expression levels were significantly reduced by treatment of Tangwang Mingmu Granules (P<0.05). Conclusion The preventive and therapeutic effect of Tangwang Mingmu Granules on diabetic retinopathy might be related to down-regulate the expression of inflammation-associated cytokines of mRNA and protein, such as TNF-α and IL-1α.

Key words:Tangwang Mingmu Granules;diabetic retinopathy;tumor necrosis factor-α;interleukin-1α;human umbilical vein endothelial cell

基金项目:北京市科技计划“十病十药”中药专项(Z121102001112007)

通讯作者:连增林,E-mail:zenglinlian@aliyun.com

糖网明目颗粒是基于中国中医科学院眼科医院高健生教授治疗糖尿病视网膜病变(diabetic retinopathy,DR)的密蒙花方开发的中药6类新药[1]。临床观察显示,该方对提高DR患者视力、改善视疲劳等临床症状及眼底血管状态疗效显著[2-3]。本课题前期研究结果表明,优化工艺制备的糖网明目颗粒提取物与传统水煎煮工艺比较能明显改善糖尿病大鼠视网膜微血管病理学状态,降低血管生成相关因子的蛋白水平[4]。本实验采用血管内皮细胞模拟DR缺氧/高糖病理环境,进一步探讨缺氧/高糖状态下糖网明目颗粒提取物对人脐静脉内皮细胞EA.hy926炎症相关因子的作用效果,并阐释该药防治DR的作用机制。

1 实验材料

1.1 细胞

人脐静脉内皮细胞EA.hy 926,购于中国科学院上海细胞库。

1.2 药物

糖网明目颗粒处方由女贞子、乌梅……

登录APP查看全文